Results 11 to 20 of about 15,976 (198)

Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization [PDF]

open access: yesInternational Journal of Ophthalmology
AIM: To report the 24mo outcomes of vascular endothelial growth factor (VEGF) inhibitors for myopic choroidal neovascularization (mCNV) in routine clinical practice and simultaneously evaluated the real-world safety.
Jing-Yao Liu, Ju-Ping Liu, Xiao-Rong Li
doaj   +3 more sources

ASSESSMENT AND ROLE OF ARTERY-VEIN COMPLEX IN MYOPIC CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. [PDF]

open access: hybridRetina, 2023
Perforating scleral vessels (PSVs) have been linked to more aggressive CNV lesions in highly myopic patients. The results of this study show that the presence of an artery–vein complex, formed by a PSV and a dilated choroidal vein, lead to less ...
Ruiz-Medrano J   +6 more
europepmc   +3 more sources

Choroidal Morphologic and Vascular Features in Patients With Myopic Choroidal Neovascularization and Different Levels of Myopia Based on Image Binarization of Optical Coherence Tomography [PDF]

open access: yesFrontiers in Medicine, 2022
Purpose: To characterize the choroidal morphologic and vascular features in different levels of myopes and patients with myopic choroidal neovascularization (mCNV).Methods: A total of 148 subjects were enrolled in this cross-sectional study, including 78
Xinglin Wang   +11 more
doaj   +3 more sources

An ImageJ macro tool for OCTA-based quantitative analysis of Myopic Choroidal neovascularization. [PDF]

open access: goldPLoS One, 2023
Myopic Choroidal neovascularization (mCNV) is one of the most common vision-threatening com- plications of pathological myopia among many retinal diseases.
Deshpande A   +4 more
europepmc   +4 more sources

Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti-vascular endothelial growth factor. [PDF]

open access: goldKaohsiung J Med Sci, 2023
In recent years, optical coherence tomography (OCT) biomarkers for specific retinal diseases have been found to be associated with treatment outcome and disease recurrence.
Lee DY, Wu PY, Sheu SJ.
europepmc   +4 more sources

Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment. [PDF]

open access: goldPLoS One, 2022
Purpose The study aimed to evaluate risk factors for macular atrophy (MA) associated with myopic choroidal neovascularization (mCNV) during long-term follow-up after intravitreal anti-vascular endothelial growth factor (VEGF) treatment in highly myopic ...
Bae KW   +6 more
europepmc   +4 more sources

Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy. [PDF]

open access: goldFront Med (Lausanne), 2022
Background This study aimed to summarize the features of perforating scleral vessels (PSVs) in patients with myopic choroidal neovascularization (CNV) (mCNV) using optical coherence tomography angiography (OCTA) and to identify the associations with the ...
Yao W   +11 more
europepmc   +4 more sources

Morphologic Features of Myopic Choroidal Neovascularization in Pathologic Myopia on Swept-Source Optical Coherence Tomography [PDF]

open access: yesFrontiers in Medicine, 2020
Purpose: To investigate the morphologic features and identify the risk factors of myopic choroidal neovascularization (CNV).Methods: Eighty-eight eyes of 69 consecutive patients with myopic CNV were included in this study. About 109 eyes of 78 pathologic
Jiamin Xie   +40 more
doaj   +2 more sources

Factors affecting visual outcome of myopic choroidal neovascularization treated with verteporfin photodynamic therapy

open access: greenInternational Journal of Ophthalmology, 2013
AIM: To evaluate the visual outcomes of choroidal neovascularization (CNV) secondary to pathological myopia and the impact of novel risk factors affecting the final visual outcome.
Tock-Han Lim   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy